Hepcinat-LP, also known as “HARVONI®, Hepcvilr L, Myhep lvir” is a fixed-dose combination of Sofosbuvir and Ledipasvir indicated for the treatment of chronic hepatitis C virus (HCV). Hepcinat-LP combines Sofosbuvir 400mg and Ledipasvir90mg. Its Cure rates is 94% to 99% for hepatitis C. Sofosbuvir 100mg/Velpatasvir 40 mg’s brand name is HARVONI® by Gilead. Hepcinat-LP is a generic oncologic prescription medicine from Natco, which is one of the biggest pharmaceutical company in India.
